30430
Manuela Abreu, Sofia Barbosa, Ricardo Prata
79. Salazar DE, Dockens RC, Milbrath RL, et al. Pharmacokinetic and pharmacodynamics evalua-
tion of warfarin and nefazodone coadministration in healthy subjects. J Clin Pharmacol.
1995;35:730‑8.
80. Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions upda-
ted. Br J Pharmacol. 2007; 151:737‑48.
81. Pond SM, Graham GG, Birkett DJ, et al. Effects of tricyclic antidepressants on drug metabo-
lism. Clin Pharmacol Ther. 1975; 18:191‑9.
82. Loomis CW, Racz WJ. Drug Interactions of amitriptyline and nortriptyline with warfarin in
the rat. Res Commun Chem Pathol Pharmacol. 1980; 30:41‑58.
83. Mayersohn M, Guentert TW. Clinical pharmacokinetics of the monoamine oxidase‑A inhibi-
tor moclobemide. Clin Pharmacokinet. 1995; 29:292‑332.
84. Henderson L, Yue QY, Bergquist C, et al. St. John’s wort (Hypericum perforatum): drug
interactions and clinical outcomes. Br J Clin Pharmacol. 2002; 54:349‑56.
85. Xuemin J, Williams KM, Liauw WS, et al. Effects of St. John’s wort and ginseng on the phar-
macokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol.
2004; 57:592‑9.
86. Orme M, Breckenridge A, Brooks RV. Interactions of benzodiazepines with warfarin. Br Med
J. 1972; 9:611‑4.
87. Gammans RE, Mayol RF, LaBuddle JA. Metabolism and disposition of buspirone. Am J Med.
1986; 80:41‑51.
88. Dolder C, Nelson M, McKinsey J. Use of non‑benzodiazepine hypnotics in the elderly: are all
agents the same? CNS Drugs. 2007; 21:389‑405.
89. Boston Collaborative Drug Surveillance Program. Interaction between chroral hydrate and
warfarin. N Engl J Med. 1972; 286:53‑5.
90. Williams S, Wynn G, Cozza K, et al. Cardiovascular medications. Psychosomatics. 2007;
48:537‑47.
91. Strain JJ, Caliendo G, Alexis JD, et al. Cardiac drug and psychotropic drug interactions: signi-
ficance and recommendations. Heart Dis. 2001; 3:248‑62.
92. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial
fibrillation. N Engl J Med. 2009; 361:1139‑51.
93. Pradaxa® (dabigatran etexilate) prescriber guide for stroke prevention in atrial fibrillation.
Available at
.
94. Ariyo AA, Haan M, Tangen CM, et al. Depressive symptoms and risks of coronary heart
disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative
Research Group 1. Circulation. 2000; 102:1773‑9.
95. Ladwig KH, Kieser M, Konig J, et al. Affective disorders and survival after acute myocardial
infarction. Results from the post infarction late potential study. Eur Heart J. 1991; 12:959‑6.
